In a huge boost to those suffering rare cancers, yesterday the Government announced an additional $50M in funding for the Genomic Cancer Medicine Program, centred at Garvan.
In Australia, more than 52,000 people are diagnosed each year with a rare or less common cancer. Of these, 25,000 will die as there are few treatment options available for these cancers.
The original Genomic Cancer Medicine Program was made possible by an investment of $7 million over four years by the NSW Government. Since October 2016, over 1,000 Australians with early onset, rare and less common cancers have travelled from all over Australia to The Kinghorn Cancer Centre in Darlinghurst, Sydney to participate in these Garvan led research studies and clinical trials.
This Federal funding will enable critical access for people with early onset, advanced rare or less common cancers to genomic cancer medicine clinical trials, through a network of eight leading cancer centres in every state and territory throughout Australia, led by the Garvan Institute.
Find out more here